Počet záznamů: 1
Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options
- 1.
SYSNO ASEP 0556628 Druh ASEP J - Článek v odborném periodiku Zařazení RIV O - Ostatní Poddruh J Článek ve WOS Název Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options Tvůrce(i) Hrnčíř, Tomáš (MBU-M) RID, ORCID Celkový počet autorů 1 Číslo článku 578 Zdroj.dok. Microorganisms. - : MDPI
Roč. 10, č. 3 (2022)Poč.str. 7 s. Jazyk dok. eng - angličtina Země vyd. CH - Švýcarsko Klíč. slova sulfate-reducing bacteria ; intestinal microbiota ; ulcerative-colitis ; insulin-resistance ; diabetes-mellitus ; obeticholic acid ; transplantation ; severity ; disease ; phosphatidylcholine Vědní obor RIV EE - Mikrobiologie, virologie Obor OECD Microbiology CEP GA20-09732S GA ČR - Grantová agentura ČR GA22-12533S GA ČR - Grantová agentura ČR Způsob publikování Open access Institucionální podpora MBU-M - RVO:61388971 UT WOS 000778263300001 EID SCOPUS 85126012626 DOI 10.3390/microorganisms10030578 Anotace The global incidence of numerous immune-mediated, metabolic, neurodegenerative, and psychiatric diseases is steadily increasing. The increased morbidity of human populations makes them more vulnerable to additional burdens, including infectious diseases. For example, the mortality rate of diabetics infected with the original variant of the SARS Co-2 virus was about twice that of the general population. It is becoming increasingly clear that the gut microbiota plays an important role in the development of many, if not all, of these diseases. Many of these diseases, including COVID-19 infection, are associated with alterations in the composition and function of the gut microbiota, i.e., dysbiosis. The focus of this special issue was on all possible triggers of gut microbiota dysbiosis and on exploring ways to restore the gut microbiota, such as nutritional interventions, probiotics, and FMT, to identify disease-associated microbiota signatures, elucidate pathogenetic mechanisms, find new diagnostic and prognostic markers, and develop new microbiota-based treatments Pracoviště Mikrobiologický ústav Kontakt Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231 Rok sběru 2023 Elektronická adresa https://www.mdpi.com/2076-2607/10/3/578
Počet záznamů: 1